Continuous glucose monitoring reveals bimodal glycemic patterns during and outside Capivasertib administration

ABSTRACT Capivasertib, an AKT inhibitor, interferes with insulin signaling and can induce hyperglycemia. In this case, we monitored blood glucose fluctuations using continuous glucose monitoring (CGM) during capivasertib administration. During the administration period, a post‐dose increase in blood...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yuya Suzuki, Takeshi Yamaguchi, Takayasu Uchida, Kimio Matsumura, Nozomi Harai, Kaoru Nagasawa, Yuko Tanabe, Koichi Suyama, Takashi Kadowaki, Yasumichi Mori
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2026-04-01
Colecção:	Journal of Diabetes Investigation
Assuntos:	Capivasertib Continuous glucose monitoring Hyperglycemia
Acesso em linha:	https://doi.org/10.1111/jdi.70261
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!